Publications in collaboration with researchers from Johns Hopkins University (19)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    Blood, Vol. 140, Núm. 11, pp. 1200-1228

  2. MDS-110 SELECT-MDS-1 Trial in Progress: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene/Azacitidine Versus Placebo/Azacitidine in Newly Diagnosed Adult Patients Selected for RARA-Positive Higher-Risk MDS

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S303-S304

2021

  1. Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series

    EBioMedicine, Vol. 67

2018

  1. Shifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017

    AIDS Research and Human Retroviruses

2017

  1. Changes in bone turnover markers with HIV seroconversion and ART initiation

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 5, pp. 1456-1461

2015

  1. A global reference for human genetic variation

    Nature, Vol. 526, Núm. 7571, pp. 68-74

  2. Accelerated longitudinal gait speed decline in HIV-infected older men

    Journal of Acquired Immune Deficiency Syndromes, Vol. 70, Núm. 4, pp. 370-376

2014

  1. Inaccuracy of haemoglobin A1c among HIV-infected men: Effects of CD4 cell count, antiretroviral therapies and haematological parameters

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 12, pp. 3360-3367

  2. Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel

    Nature Communications, Vol. 5

2012

  1. An integrated map of genetic variation from 1,092 human genomes

    Nature, Vol. 491, Núm. 7422, pp. 56-65

2010

  1. Comparison of interlaboratory variation in absolute T-cell counts by single-platform and optimized dual-platform methods

    Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. 3, pp. 194-200

2008

  1. Hemodynamic and inflammatory markers of sleep apnea-hypopnea syndrome and nocturnal hypoxemia: Effects of treatment with nasal continuous positive airway pressure

    Archivos de Bronconeumologia, Vol. 44, Núm. 10, pp. 531-539

2007

  1. Assessing immunophenotyping performance: Proficiency-validation for adopting improved flow cytometry methods

    Cytometry Part B - Clinical Cytometry, Vol. 72, Núm. 4, pp. 249-255

2006

  1. Impact of inversion of the CD4/CD8 ratio on the natural history of HIV-1 infection

    Journal of Acquired Immune Deficiency Syndromes, Vol. 42, Núm. 5, pp. 620-626

2002

  1. Validity of self-reporting of episodes of external genital warts

    Clinical Infectious Diseases, Vol. 35, Núm. 1, pp. 39-45

2000

  1. Minimal number of reagents required to evaluate hematolymphoid neoplasias: Results of an international consensus meeting

    CYTOMETRY

1996

  1. Virologic and Serologic Markers of Rapid Progression to AIDS after HIV-1 Seroconversion

    Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 13, Núm. 5, pp. 448-455

1995

  1. Failure of t-cell homeostasis preceding AIDS in HIV-1 infection

    Nature Medicine, Vol. 1, Núm. 7, pp. 674-680